Regeneron Pharmaceuticals Inc.

History

YearDetail
1988 Regeneron was founded.
1990 Announced a collaboration to develop neurotrophic factors.
1992 Clinical development of investigational drug, a neurotrophic factor, begins.
2000 Investigational medicine rilonacept begins clinical exploration.
2004 Investigational medicine aflibercept begins clinical development.
2006 Entered a collaboration with Bayer HealthCare.
2007 The company collaborated with Sanofi.
2008 The FDA approved first medicine, ARCALYST Injection.
2013 European business office opens in Dublin, Ireland.
2015 Launched a major new immuno-oncology collaboration with Sanofi.
2022 The company acquried Checkmate Pharmaceuticals.